Calgary, AB – TheNewswire - November 08, 2022 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, is pleased to announce the formation of an external Advisory Board as part of its strategic plans and mission to deliver medicalized ibogaine-centered addiction care and to undertake a planned clinical trial [...]

Calgary, AB – TheNewswire - October 5, 2022 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, is pleased to announce that all resolutions were passed by the requisite majority of shareholders at its annual general meeting (“ AGM ”) which was held on October 3, 2022 in Vancouver, BC. UI’s five incumbent [...]

Calgary, AB – TheNewswire - October 3, 2022 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that it is in process of finalizing an offering (the “ Offering ”) of convertible debt securities.  The Offering will consist of “Secured Guarantee Convertible Notes” (the “ Notes ”) which will bear interest at 8% (payable [...]

Calgary, AB – TheNewswire - September 26 , 2022 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, is pleased to announce it has been featured in a documentary series entitled Psychedelics Tonight , which was co-produced by Kyle Buller and Joe Moore of Psychedelics Today in partnership with ALTRD.TV. The docuseries provides information on [...]

Calgary, AB – TheNewswire - September 22, 2022 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that it’s research and development clinic, the Kelburn Mental Health and Addiction Recovery Center is scheduled to reopen and commence business operations on October 17, 2022 . Dr Ian Rabb, Universal Ibogaine Chief [...]

Calgary, AB – September 6, 2022 – Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that it has appointed Nicholas (“Nick”) Karos, CEO of the Company, to its Board of Directors of UI effective September 6, 2022.  UI will hold its Annual Meeting of Shareholders in [...]

Calgary, AB – August 19, 2022 – Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”) is a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care. Ibogaine is a plant derived medicine used in addiction treatment and has been shown to deliver detoxification from opioids, heroin and other substances, and can provide a several month window free [...]

Calgary, AB – TheNewswire - June 24, 2022 – Universal Ibogaine Inc. (TSXV:IBO ) , ( OTC:IBOGF ) and ( FSE:JC4) (“ UI ” or the “ Company ”) a life sciences company with a mission to transform addiction treatment using medicalized ibogaine and a global licensing model is pleased to announce that Nick Karos, CEO will present at the H.C. Wainwright 1 st Annual Mental Health Conference: Neuropsychiatry, Psychedelics and Beyond.  The event is a hybrid online and [...]

Calgary, AB – TheNewswire - June 13, 2022 – Universal Ibogaine Inc. (TSXV:IBO ) , ( OTC:IBOGF ) and ( FSE:JC4) (“ UI ” or the “ Company ”) a life sciences company with a mission to transform addiction treatment through the use of medicalized ibogaine and a global licensing model advises it has engaged investor communications firm Blue Digital Media & Web Solutions (“ Blue Digital ”) for assistance with expanding awareness of UI’s business activities. Blue Digital [...]

Calgary, AB – TheNewswire - June 10, 2022 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”) a life sciences company with a mission to develop and deliver medicalized ibogaine-centered addiction care, advises that David Danziger has resigned as a member of the UI Board of Directors. UI thanks David for his contributions to the Company during his tenure as a Director [...]